Chelsea Gerada

522 total citations · 1 hit paper
6 papers, 380 citations indexed

About

Chelsea Gerada is a scholar working on Epidemiology, Immunology and Molecular Biology. According to data from OpenAlex, Chelsea Gerada has authored 6 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 4 papers in Immunology and 2 papers in Molecular Biology. Recurrent topics in Chelsea Gerada's work include Herpesvirus Infections and Treatments (3 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Immune cells in cancer (2 papers). Chelsea Gerada is often cited by papers focused on Herpesvirus Infections and Treatments (3 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Immune cells in cancer (2 papers). Chelsea Gerada collaborates with scholars based in Australia, United Kingdom and United States. Chelsea Gerada's co-authors include Barry Slobedman, Allison Abendroth, Megan Steain, Brian P. McSharry, Tessa M. Campbell, Kevin M. Ryan, Jean‐Martin Lapointe, Jim Eyles, Marina Natoli and Kathy Mulgrew and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Virology and Frontiers in Immunology.

In The Last Decade

Chelsea Gerada

6 papers receiving 375 citations

Hit Papers

Manipulation of the Innate Immune Response by Varicella Z... 2020 2026 2022 2024 2020 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chelsea Gerada Australia 4 142 124 116 66 44 6 380
Tessa M. Campbell Australia 8 198 1.4× 159 1.3× 103 0.9× 69 1.0× 48 1.1× 10 463
Nahid Zainodini Iran 12 169 1.2× 111 0.9× 164 1.4× 24 0.4× 47 1.1× 39 482
Soyoon Ryoo South Korea 11 178 1.3× 75 0.6× 145 1.3× 66 1.0× 93 2.1× 37 497
Jhen Tsang United Kingdom 10 189 1.3× 77 0.6× 181 1.6× 62 0.9× 34 0.8× 10 451
Mohammad Kazemi Arababadi Iran 12 163 1.1× 93 0.8× 103 0.9× 46 0.7× 30 0.7× 28 378
Mi-Hee Lee South Korea 11 256 1.8× 118 1.0× 150 1.3× 32 0.5× 26 0.6× 35 567
Sarah M. Tete Norway 10 138 1.0× 121 1.0× 72 0.6× 40 0.6× 39 0.9× 18 392
Keren M. Rabinowitz Israel 10 102 0.7× 113 0.9× 165 1.4× 51 0.8× 32 0.7× 22 401
Katie L. Alexander United States 9 144 1.0× 61 0.5× 206 1.8× 52 0.8× 44 1.0× 18 399
Ana Flávia Popi Brazil 14 250 1.8× 92 0.7× 98 0.8× 43 0.7× 39 0.9× 25 440

Countries citing papers authored by Chelsea Gerada

Since Specialization
Citations

This map shows the geographic impact of Chelsea Gerada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chelsea Gerada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chelsea Gerada more than expected).

Fields of papers citing papers by Chelsea Gerada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chelsea Gerada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chelsea Gerada. The network helps show where Chelsea Gerada may publish in the future.

Co-authorship network of co-authors of Chelsea Gerada

This figure shows the co-authorship network connecting the top 25 collaborators of Chelsea Gerada. A scholar is included among the top collaborators of Chelsea Gerada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chelsea Gerada. Chelsea Gerada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Natoli, Marina, Fabien Garçon, Rodrigo Aguilera Olvera, et al.. (2024). 1073 AZD5863, a CLDN18.2 and CD3 binding T-cell engager, establishes a multi-faceted antitumour immune response and combines effectively with chemo-immunotherapy regimens. Regular and Young Investigator Award Abstracts. A1194–A1194. 1 indexed citations
2.
Candido, Juliana, Gozde Kar, Fabien Garçon, et al.. (2023). 785 mAZD0171 mediated LIF blockade in combination with chemotherapy and PD-L1 inhibition repolarizes macrophages and increases T cell infiltration via CX3CR1-CX3CL1 axis. SHILAP Revista de lepidopterología. A882–A882. 1 indexed citations
3.
Gerada, Chelsea, Tessa M. Campbell, Brian P. McSharry, et al.. (2020). Manipulation of the Innate Immune Response by Varicella Zoster Virus. Frontiers in Immunology. 11. 1–1. 260 indexed citations breakdown →
4.
Gerada, Chelsea & Kevin M. Ryan. (2020). Autophagy, the innate immune response and cancer. Molecular Oncology. 14(9). 1913–1929. 77 indexed citations
5.
Gerada, Chelsea, Megan Steain, Tessa M. Campbell, et al.. (2019). Granzyme B Cleaves Multiple Herpes Simplex Virus 1 and Varicella-Zoster Virus (VZV) Gene Products, and VZV ORF4 Inhibits Natural Killer Cell Cytotoxicity. Journal of Virology. 93(22). 19 indexed citations
6.
Gerada, Chelsea, Megan Steain, Brian P. McSharry, Barry Slobedman, & Allison Abendroth. (2018). Varicella-Zoster Virus ORF63 Protects Human Neuronal and Keratinocyte Cell Lines from Apoptosis and Changes Its Localization upon Apoptosis Induction. Journal of Virology. 92(12). 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026